CASI Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements

15 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sublicense Agreement between CASI Pharmaceuticals, Inc. and Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd. (May 23, 2022)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2022
License and Development Agreement for CB-5339 between Cleave Therapeutics, Inc. and CASI Pharmaceuticals, Inc.
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2021
License Agreement between Talon Therapeutics, Inc. and CASI Pharmaceuticals, Inc. for Marqibo®
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
License Agreement between Spectrum Pharmaceuticals Cayman, L.P. and CASI Pharmaceuticals, Inc. for Ibritumomab Tiuxetan Product
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
License Agreement between Spectrum Pharmaceuticals, Inc. and CASI Pharmaceuticals, Inc. for Melphalan Product
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
CA
2021
Supplementary Agreement to Exclusive License Agreement between Juventas Cell Therapy Ltd. and CASI Pharmaceuticals, Inc.
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Exclusive License Agreement between Juventas Cell Therapy Ltd. and CASI Pharmaceuticals, Inc. (June 15, 2019)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2019
License Agreement between CASI Pharmaceuticals, Inc. and Black Belt Therapeutics Limited (April 16, 2019)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2019
License Agreement between Talon Therapeutics, Inc. and CASI Pharmaceuticals, Inc. for Marqibo®
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2014
License Agreement between Spectrum Pharmaceuticals Cayman, L.P. and CASI Pharmaceuticals, Inc. (Ibritumomab Tiuxetan Product)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2014
License Agreement between Spectrum Pharmaceuticals, Inc. and CASI Pharmaceuticals, Inc. (Melphalan Product)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
CA
2014
China Rights Agreement between Selected Value Therapeutics I, LLC and EntreMed, Inc.
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2010
License Agreement between Elan Pharma International Limited and EntreMed, Inc. (January 9, 2006)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2006
License Agreement Between EntreMed, Inc. and Celgene Corporation Dated March 23, 2005
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2005
Analog License Agreement between Children's Medical Center Corporation and EntreMed, Inc. (August 6, 2001)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MA
2001